Rehabilitation of patients with urolithiasis after minimally invasive procedures on kidneys


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Minimally invasive surgeries in patients with urolithiasis are not always successful. Prevention of inflammatory and cicatrical-sclerotic complications in the postoperative period plays an important role. 49 patients with urolithiasis divided into two groups were followed-up. The study group included 25 patients who underwent percutaneous puncture nephrolitholapaxy. The control group consisted of 24 patients with a history of percutaneous puncture nephrolitholapaxy. In postoperative period, active prevention of inflammation and cicatrical-sclerotic complications using drug Longidaza® in combination with magnetic-laser therapy was performed in study group. The control group received standard treatment. 6 months after surgery, 1 (4%) patient in the study group had pyeloectasis ~2 cm and obstruction of UPJ of operated kidney, which required re-treatment with Longidaza®. In the control group, pyeloectasis and violation of passage through the upper urinary tract were recorded in 4 (16,7%) patients. These data allow to recommend a comprehensive prevention of postoperative inflammation and cicatrical-sclerotic complications using Longidaza and magnetic-laser therapy in patients undergoing minimally invasive surgery of the kidney.

Full Text

Restricted Access

References

  1. Mitropoulos D., Artibani W., Graefen M. et al. Reporting and grading of complications after urologic surgical procedures: an ad hoc EAU Guidelines Panel Assessment and Recommendations. Eur. Urol. 2012;61(2):341-49.
  2. Акулин С.М. Осложнения оперативных вмешательств при лечении больных коралловидным нефролитиазом (лечение и профилактика): Автореф. дисс. канд. мед. наук. М., 2010.
  3. Клинические рекомендации. Урология / Под ред. Н.А. Лопаткина. М.: ГЭОТАР-Медиа, 2007.
  4. Братчиков О.И., Веденьев Ю.И., Мягченко С.В. Клиникоморфологические особенности при гидронефрозе. Пленум Правления Российского общества урологов: тезисы. К., 2010. С. 27.
  5. Kazeko N.I., Khilkevich S.V. Clinicobiochemical and immunological assessment of polyoxidonium efficacy in the treatment of patients with chronic calculous pyelonephritis. Urologiia. 2011;22(6):5.
  6. Козлов В.И. Гистофизиология системы микроциркуляции. Регионарное кровообращение и микроциркуляция. 2003;2(4):79-85.
  7. Nickel J. AUA. Annual Meeting. May, 2000. Faculty. P. 738.
  8. Papatsoris A., Chrisofos M. et al. Update on intracorporeal laser lithotripsy. Minerva Med. 2013;104(1):55-60.
  9. Paz Z., Shoenfeld Y. Antifibrosis: to reverse the irreversible. Clin. Rev. Allergy Immunol. 2010;276(3):86-91.
  10. Авдошин В.П., Андрюхин М.И., Кирюхина Т.А. Профилактика рубцово-склеротических осложнений после операций на верхних мочевых путях. Эффективная фармакотерапия. Урология. 2012;2:6-11.
  11. Михайликов Т.Г. Ферментная и магнитолазерная терапия в комплексном лечении больных хроническим простатитом: Автореф. дис. канд. нед. наук. М., 2009. С. 3.
  12. Низкоинтенсивная лазерная терапия / Под общей редакцией С.В. Москвина, В.А. Буйлина. М., ТОО «Фирма "Техника"». 2000. 724 с.
  13. Авдошин В.П. Применение низкоинтенсивного лазерного излучения в комплексном лечении урологических больных. IV Всероссийская научно-практическая конференция по квантовой терапии: тезисы. М., 1997. С. 87-89.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2013 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies